Radiation therapy for operable breast cancer sixty years of progress as seen through the articles published in the journal cancer

Cancer

Volumn 113, Issue 7, 2008, Pages 1779-1800

  Freedman, G M ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Breast cancer; Breast conserving surgery; Mastectomy; Radiotherapy

Indexed keywords

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; HUMAN; MASTECTOMY; PRIORITY JOURNAL; REVIEW;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC IRRADIATION; MASTECTOMY; NEOPLASM RECURRENCE, LOCAL; SURVIVAL RATE;

EID: 53949097173     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23646     Document Type: Review

References (211)

1. Stewart FW, Treves N. Lymphangiosarcoma in postmastectomy lymphedema. A report of six cases in elephantiasis chirurgica. Cancer. 1948;1:64-81.
2. Collins VP. Breast cancer: the influence of treatment that fails to cure. Cancer. 1956;9:1177-1181.
3. Powers WE. Breast cancer - preoperative and postoperative radiation therapy. Cancer. 1969;24:1301-1306.
4. Burdick D, Chanatry F. Central New York Surgical Society survey of breast carcinoma, 1920 to 1952. Cancer. 1954;7:47-53.
5. Robnett AH, Jones TE, Hazard JB. Carcinoma of the breast. Recurrence and survival in 203 patients. Cancer. 1950;3:757-772.
6. Hochman A, Robinson E. Eighty-two cases of mammary cancer treated exclusively with roentgen therapy. Cancer. 1959;13:670-673.
7. Butcher HR Jr, Seaman WB, Eckert C, Saltzstein S. An assessment of radical mastectomy and postoperative irradiation therapy in the treatment of mammary Cancer. Cancer. 1963;17:480-485.
8. Zimmerman KW, Montague ED, Fletcher GH. Frequency, anatomical distribution and management of local recurrences after definitive therapy for breast Cancer. Cancer. 1966;19:67-74.
9. Fletcher GH, Montague ED, White EC. Evaluation of irradiation of the peripheral lymphatics in conjunction with radical mastectomy for cancer of the breast. Cancer. 1968;21:791-797.
10. Johns HE. Newer radiotherapeutic sources of radiation and the distributions that they produce in biological materials. Cancer. 1960;13(suppl 6):5-15.
11. Treves N. An evaluation of the etiological factors of lymphedema following radical mastectomy. Cancer. 1957;3:444-459.
12. Meurk ML. Dosimetric considerations in radiation therapy of cancer of the breast. Cancer. 1972;29:552-556.
13. Friedman HA. Problems of dosimetry of new modes of radiation. Cancer. 1960;13(suppl 6):16-25.
14. Kagan AR, Nussbaum H. Cancer of the breast: is postoperative irradiation indicated? Cancer. 1972;29:561-565.
15. Bedwinek J. Adjuvant irradiation for early breast Cancer. An on-going controversy. Cancer. 1984;53:729-739.
16. Ross WI. A look into the past and into the future in cancer of the breast. Cancer. 1969;23:762-766.
17. Cutler SJ, Heise HW. Efficacy of current treatment methods in cancer of the breast. Cancer. 1969;24:1117-1122.
18. Montague ED. Adaptation of irradiation techniques to various types of surgical procedures for breast Cancer. Cancer. 1972;29:557-560.
19. Fletcher GH. Local results of irradiation in the primary management of localized breast Cancer. Cancer. 1972;29:545-551.
20. Fisher B. Status of adjuvant therapy: results of the National Surgical Adjuvant Breast Project studies on oophorectomy, postoperative radiation therapy, and chemotherapy. Cancer. 1971;28:1654-1658.
21. Fisher B. Cooperative clinical trials in primary breast cancer: a critical appraisal. Cancer. 1973;31:1271-1286.
22. Raventos A. Postoperative radiation therapy. Cancer. 1971;28:1651-1653.
23. Levitt SH, McHugh RB, Song CW. Radiotherapy in the postoperative treatment of operable cancer of the breast. Cancer. 1976;39:933-940.
24. Levitt SH, McHugh RB. Radiotherapy in the postoperative treatment of operable cancer of the breast. Pt I. Critique of the clinical and biometric aspects of the trials. Cancer. 1977;39:924-932.
25. Albert S, Belle S, Swanson GM. Recent trends in the treatment of primary breast Cancer. Cancer. 1978;41:2399-2404.
26. Vana J, Bedwani R, Mettlin C, Murphy GP. Trends in diagnosis and management of breast cancer in the U.S.: from the surveys of the American College of Surgeons. Cancer. 1981;48:1043-1052.
27. Stjernsward J. Adjuvant radiotherapy trials in breast Cancer. Cancer. 1977;39:2846-2867.
28. Brady LW, Fletcher GH, Levitt SH. Cancer of the breast. The role of radiation therapy after mastectomy. Cancer. 1977;39(6 suppl):2868-2874.
29. Weichselbaum RR, Marck A, Hellman S. The role of postoperative irradiation in carcinoma of the breast. Cancer. 1976;37:2682-2690.
30. Chahbazian CM, Del Regato JA, Wilson JF. Postoperative radiation therapy for "early" carcinoma of the breast. Cancer. 1978;42:1126-1128.
31. Urban JA. Management of operable breast Cancer. The surgeon's view. Cancer. 1978;42:2066-2077.
32. Fisher B, Montague E, Redmond C, et al. Comparison of radical mastectomy with alternative treatments for primary breast Cancer. Cancer. 1977;39:2827-2839.
33. Forrest APM. Conservative local treatment of breast Cancer. Cancer. 1977;39:2813-2821.
34. Wallgren A, Arner O, Bergstrom J, et al. Preoperative radiotherapy in operable breast cancer: results in the Stockholm Breast Cancer Trial. Cancer. 1978;42:1120-1125.
35. Tapley ND, Spanos WJ Jr, Fletcher GH, Montague ED, Schell S, Oswald MJ. Results in patients with breast cancer treated by radical mastectomy and postoperative irradiation with no adjuvant chemotherapy. Cancer. 1982;49:1316-1319.
36. Rodger A, Montague ED, Fletcher GH. Preoperative or postoperative irradiation as adjunctive treatment with radical mastectomy in breast Cancer. Cancer. 1983;51:1388-1392.
37. Nemoto T, Natarajan N, Bedwani R, Vana J, Murphy GP. Breast cancer in the medial half. Results of 1978 National Survey of the American College of Surgeons. Cancer. 1983;51:1333-1338.
38. Buzdar AU, Blumenschein GR, Smith TL, et al. Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without bacillus calmette-guerin and with or without irradiation in operable breast Cancer. A prospective randomized trial. Cancer. 1984;53:384-389.
39. Nevin JE, Baggerly JT, Laird TK. Radiotherapy as an adjuvant in the treatment of carcinoma of the breast. Cancer. 1982;49:1194-1200.
40. Chu AM, Kiel K. Comparison of adjuvant postoperative radiotherapy and multiple-drug chemotherapy (CMF-VP) in operable breast cancer patients with more than 4 positive axillary lymph nodes. Cancer. 1982;50:212-218.
41. Grohn P, Heinonen E, Klefstrom P, Tarkkanen J. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast Cancer. Cancer. 1984;54:670-674.
42. Klefstrom P, Grohn P, Heinonen E, Holsti L, Holsti P. Adjuvant postoperative radiotherapy, chemotherapy and immunotherapy in stage III breast Cancer. Cancer. 1987;60:936-942.
43. Cooper MR, Rhyne AL, Muss HB, et al. A randomized comparative trial of chemotherapy and irradiation therapy for stage II breast Cancer. Cancer. 1981;47:2833-2839.
44. Papaioannou A, Lissaios B, Vasilaros S, et al. Pre- and postoperative chemoendocrine treatment with or without postoperative radiotherapy for locally advanced breast Cancer. Cancer. 1983;51:1284-1290.
45. Levine JF, Coleman CN, Cox RS, et al. The effect of postoperative and primary radiation therapy on delivered dose of adjuvant cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy in breast Cancer. Cancer. 1984;53:237-241.
46. Rosenman J, Bernard S, Kober C, Leland W, Varia M, Newsome J. Local recurrences in patients with breast cancer at the North Carolina Memorial Hospital (1970-1982). Cancer. 1986;57:1421-1425.
47. Pisansky TM, Ingle JN, Schaid DJ, et al. Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node-positive breast Cancer. Impact on clinical, histopathologic and flow cytometric factors. Cancer. 1993;72:1247-1260.
48. Buzdar AU, McNeese MD, Hortobagyi GN, et al. Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer? Cancer. 1990;65:394-399.
49. Swedborg I, Wallgren A. The effect of pre- and postmastectomy radiotherapy on the degree of edema, shoulderjoint mobility, and gripping force. Cancer. 1981;47:877-881.
50. Ferguson DJ, Sutton HG Jr, Dawson PJ. Late effects of adjuvant radiotherapy for breast Cancer. Cancer. 1984;54:2319-2323.
51. Loeffler RK. A technique for the local and regional control of carcinoma of the breast using 25-MeV x radiation. Cancer. 1975;36:1496-1505.
52. Cady B. New diagnostic, staging, and therapeutic aspects of early breast Cancer. Cancer. 1990;65:634-647.
53. Fowble B. Postmastectomy radiation. A modest benefit prevails for high risk patients. Cancer. 1997;79:1061-1066.
54. Janjan NA, Murray KJ, Conway P, Walker A, Wilson JF. Prognosis for breast cancer surgery and radiation therapy compared with mastectomy alone. A retrospective analysis of 759 patients with stage I/II breast Cancer. Cancer. 1992;69:2842-2848.
55. Recht A, Houlihan MJ. Axillary lymph nodes and breast Cancer. A Review. Cancer. 1995;76:1491-1512.
56. Pierce LJ, Glatstein E. Postmastectomy radiotherapy in the management of operable breast Cancer. Cancer. 1994; 74:477-485.
57. Rutqvist LE, Cedermark B, Glas U, et al. Randomized trial of adjuvant tamoxifen combined with postoperative radiation therapy or adjuvant chemotherapy in postmenopausal breast Cancer. Cancer. 1990;66:89-96.
58. Olson JE, Neuberg D, Pandya KJ, et al. The role of radiotherapy in the management of operable locally advanced breast carcinoma. Results of a randomized trial by the Eastern Cooperative Oncology Group. Cancer. 1997;79:1138-1149.
59. Levitt SH. The importance of locoregional control in the treatment of breast cancer and its impact on survival. Cancer. 1994;74:1840-1846.
60. Urban JA. Radical excision of the chest wall for mammary Cancer. Cancer. 1951;4:1263-1285.
61. Auchincloss H Jr. The nature of local recurrence following radical mastectomy. Cancer. 1957;11:611-619.
62. Urban JA. Radical mastectomy in continuity with en bloc resection of the internal mammary lymph-node chain. Cancer. 1952;5:992-1008.
63. Urban JA. Clinical experience and results of excision of the internal mammary lymph node chain in primary operable breast Cancer. Cancer. 1958;12:14-22.
64. Sugarbaker ED. Radical mastectomy combined with incontinuity resection of the homolateral internal mammary node chain. Cancer. 1953;6:969-979.
65. Guttmann RJ. Survival and results after 2-million volt irradiation in the treatment of primary operable carcinoma of the breast with proved positive internal mammary and/or highest axillary nodes. Cancer. 1961;15:383-386.
66. Greenberg HB, Jacobs S. Incidence of radiation fibrosis after use of a standardized technique of radiotherapy for breast Cancer. Cancer. 1966;19:1289-1292.
67. Donegan WL. The influence of untreated internal mammary metastases upon the course of mammary Cancer. Cancer. 1977;39:533-538.
68. Fisher B, Wolmark N, Redmond C, Deutsch M, Fisher ER. Findings from NSABP Protocol No. B-04: comparison of radical mastectomy with alternative treatments. II. The clinical and biologic significance of medial-central breast cancers. Cancer. 1981;48:1863-1872.
69. Urban JA, Castro EB. Selecting variations in extent of surgical procedure for breast Cancer. Cancer. 1971;28:1615-1623.
70. Urban JA. Changing patterns of breast Cancer. Lucy Wortham James lecture (clinical). Cancer. 1976;37:111-117.
71. Kim JH, Chu FCH, Hilaris B. The influence of dose fractionation on acute and late reactions in patients with postoperative radiotherapy for carcinoma of the breast. Cancer. 1975;35:1583-1586.
72. Munzenrider JE, Tchakarova I, Castro M, Carter B. Computerized body tomography in breast Cancer. I: Internal mammary nodes and radiation treatment planning. Cancer. 1979;43:137-150.
73. Montague ED, Fletcher GH. The curative value of irradiation in the treatment of nondisseminated breast Cancer. Cancer. 1980;46:995-998.
74. Roseman JM, James AG. The significance of the internal mammary lymph nodes in medially located breast Cancer. Cancer. 1982;50:1426-1429.
75. Sarrazin D, Le M, Rouesse J, et al. Conservative treatment versus mastectomy in breast cancer tumors with macroscopic diameter of 20 millimeters or less. The experience of the Institut Gustave-Roussy. Cancer. 1984;53:1209-1213.
76. Lacour J, Bucalossi P, Cacers E, et al. Radical mastectomy versus radical mastectomy plus internal mammary dissection: Five year results of an international cooperative study. Cancer. 1976;37:206-214.
77. Lacour J, Le M, Caceres E, Koszarowski T, Veronesi U, Hill C. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast Cancer. Cancer. 1983; 51:1941-1943.
78. Meier P, Ferguson DJ, Karrison T. A controlled trial of extended radical mastectomy. Cancer. 1985;55:880-891.
79. Meier P, Ferguson DJ, Karrison T. A controlled trial of extended radical versus radical mastectomy. Ten-year results. Cancer. 1989;63:188-195.
80. Le MG, Arriagada R, de Vathaire F, et al. Can internal mammary chain treatment decrease the risk of death for patients with medial breast cancers and positive axillary lymph nodes? Cancer. 1990;66:2313-2318.
81. Benda RK, Cendan JC, Copeland EM, et al. Should decisions on internal mammary lymph node irradiation be based on current lymphoscintigraphy techniques for sentinel lymph node identification? Cancer. 2004;100:518-523.
82. Perez CA, Fields JN, Fracasso PM, et al. Management of locally advanced carcinoma of the breast. II. Inflammatory carcinoma. Cancer. 1994;74(1 suppl):466-476.
83. Harris EER, Hwang W, Seyednejad F, Solin LJ. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy. Cancer. 2003;98:2144-2151.
84. Noguchi M, Ohta N, Koyasaki N, Taniya T, Miyazaki I, Mizukami Y. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast Cancer. Cancer. 1991;68:1918-1925.
85. Lind PA, Marks LB, Jamieson TA, et al. Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescue. Cancer. 2002;94:2821-2829.
86. Bijker N, Rutgers EJT, Peterse JL, et al. Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy. Cancer. 1999;85:1773-1781.
87. Shahar KH, Buchholz TA, Delpassand E, et al. Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast Cancer. Cancer. 2005;103:1323-1329.
88. Farrow JH, Fracchia AA, Robbins GF, Castro E. Simple excision or biopsy plus radiation therapy as the primary treatment for potentially curable cancer of the breast. Cancer. 1971;28:1195-1201.
89. Holleb AI. Cancer therapy - the patient's choice? Cancer. 1974;33:301-302.
90. Hayward J. The conservative treatment of early breast Cancer. Cancer. 1974;33:593-599.
91. Wanebo HJ, Huvos AG, Urban JA. Treatment of minimal breast Cancer. Cancer. 1974;33:349-357.
92. Rosen PP, Fracchia AA, Urban JA, Schottenfeld D, Robbins GF. "Residual" mammary carcinoma following simulated partial mastectomy. Cancer. 1975;35:739-747.
93. Ashikari R, Huvos AG, Snyder RE. Prospective study of non-infiltrating carcinoma of the breast. Cancer. 1977;39:435-439.
94. Carter D, Smith RRL. Carcinoma in situ of the breast. Cancer. 1977;40:1189-1193.
95. Prosnitz LR, Goldenberg IS. Radiation therapy as primary treatment for early stage carcinoma of the breast. Cancer. 1975;35:1587-1596.
96. Calle R, Pilleron JP, Schlienger P, Vilcoq JR. Conservative management of operable breast Cancer. Cancer. 1978;42:2045-2053.
97. Levene MB, Harris J, Hellman S. Treatment of carcinoma of the breast by radiation therapy. Cancer. 1977;39:2840-2845.
98. Hellman S, Harris JR, Levene MB. Radiation therapy of early carcinoma of the breast without mastectomy. Cancer. 1980;46:988-994.
99. Alpert S, Ghossein NA, Stacey P, Migliorelli FA, Efron G, Krishnaswamy V. Primary management of operable breast cancer by minimal surgery and radiotherapy. Cancer. 1978; 42:2054-2058.
100. Prosnitz LR, Goldenberg IS, Packard RA, et al. Radiation therapy as initial treatment for early stage cancer of the breast without mastectomy. Cancer. 1977;39:917-923.
101. Montague ED, Gutierrez AE, Barker JL, Tapley N, Fletcher GH. Conservation surgery and irradiation for the treatment of favorable breast Cancer. Cancer. 1979;43:1058-1061.
102. Veronesi U, Banfi A, Saccozzi R, et al. Conservative treatment of breast Cancer. A trial in progress at the Cancer Institute of Milan. Cancer. 1977;39:2822-2826.
103. Urban JA. Surgical management of palpable breast Cancer. Cancer. 1980;46:983-987.
104. Harris JR, Hellman S. Primary radiation therapy for early breast Cancer. Cancer. 1983;52:2547-2552.
105. Kemeny MM, Wellisch DK, Schain WS. Psychosocial outcome in a randomized surgical trial for treatment of primary breast Cancer. Cancer. 1988;62:1231-1237.
106. Lewison EF. Changing concepts in breast Cancer. Cancer. 1980;46:859-864.
107. Balawajder I, Antich PP, Boland J. The management of breast carcinoma by primary radiotherapy at Mount Sinai Hospital from 1962-1979. Cancer. 1982;49:1587-1596.
108. Amalric R, Santamaria F, Robert F, et al. Radiation therapy with or without primary limited surgery for operable breast cancer: a 20-year experience at the Marseilles Cancer Institute. Cancer. 1982;49:30-34.
109. Osborne MP, Ormiston N, Harmer CL, McKinna JA, Baker J, Greening WP. Breast conservation in the treatment of early breast Cancer. A 20-year follow-up. Cancer. 1984;53:349-355.
110. Cedermark B, Askergren J, Alveryd A, et al. Breast-conserving treatment for breast cancer in Stockholm, Sweden, 1977 to 1981. Cancer. 1984;53:1253-1255.
111. Durand JC, Poljicak M, LeFranc JP, Pilleron JP. Wide excision of the tumor, axillary dissection, and postoperative radiotherapy as treatment of small breast cancers. Cancer. 1984;53:2439-2443.
112. Kurtz JM, Amalric R, Brandone H, et al. Local recurrence after breast-conserving surgery and radiotherapy. Cancer. 1989;63:1912-1917.
113. Syed AMN, Puthawala A, Fleming P, et al. Combination of external and interstitial irradiation in the primary management of breast carcinoma. Cancer. 1980;46:1360-1365.
114. Mate TP, Carter D, Fischer DB, et al. A clinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinoma. Cancer. 1986;58:1995-2002.
115. Schnitt SJ, Connolly JL, Harris JR, Hellman S, Cohen RB. Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy. Cancer. 1984;53:1049-1057.
116. Schnitt SJ, Connolly JL, Khettry U, et al. Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy. Cancer. 1987;59:675-681.
117. Kurtz JM, Jacquemier J, Torhorst J, et al. Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer. 1989;63:1630-1635.
118. Schnitt SJ, Connolly JL, Recht A, Silver B, Harris JR. Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiation. Cancer. 1989;64:448-454.
119. Stotter AT, McNeese MD, Ames FC, Oswald MJ, Ellerbroek NA. Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast Cancer. Cancer. 1989;64:2217-2225.
120. Montague ED. Conservation surgery and radiation therapy in the treatment of operable breast Cancer. Cancer. 1984; 53:700-704.
121. Montague ED, Ames FC, Schell FC, Romsdahl MM. Conservation surgery and irradiation as an alternative to mastectomy in the treatment of clinically favorable breast Cancer. Cancer. 1984;54:2668-2672.
122. Harris JR, Beadle GF, Hellman S. Clinical studies on the use of radiation therapy as primary treatment of early breast Cancer. Cancer. 1984;53:705-711.
123. Fisher ER, Sass R, Fisher B, Gregorio R, Brown R, Wickerham L. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer. 1986;57:1717-1724.
124. Lagios MD, Richards VE, Rose MR, Yee E. Segmental mastectomy without radiotherapy. Short-term follow-up. Cancer. 1983;52:2173-2179.
125. Pickren JW, Satchidanand YK, Lane WW, Haagensen CD. Lumpectomy for mammary carcinoma. A retrospective analysis of 40 presumptive candidates from a surgical series. Cancer. 1984;54:1692-1695.
126. Holland R, Veling SHJ, Mravunac M, Hendriks JHCL. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 1985;56:979-990.
127. Zafrani B, Fourquet A, Vilcoq JR, Legal M, Calle R. Conservative management of intraductal breast carcinoma with tumorectomy and radiation therapy. Cancer. 1986;57:1299-1301.
128. Fisher ER, Sass R, Fisher B, Wickerham L, Paik SM. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 6). I. Intraductal carcinoma (DCIS). Cancer. 1986;57:197-208.
129. Lagios MD, Margolin FR, Westdahl PR, Rose MR. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer. 1989;63:618-624.
130. Ketcham AS, Moffat FL. Vexed surgeons, perplexed patients, and breast cancers which may not be Cancer. Cancer. 1990;65:387-393.
131. Morrow M. The natural history of ductal carcinoma in situ. Implications for clinical decision making. Cancer. 1995;76:1113-1115.
132. Levitt SH, Aeppli DM, Nierengarten ME. The impact of radiation on early breast carcinoma survival. Cancer. 1996;78:1035-1042.
133. Winchester DJ, Menck HR, Winchester DP. The National Cancer Data Base report on the results of a large nonrandomized comparison of breast preservation and modified radical mastectomy. Cancer. 1997;80:162-170.
134. Bland KI, Menck HR, Scott-Conner CEH, Morrow M, Winchester DJ, Winchester DP. The National Cancer Data Base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer. 1998;83:1262-1273.
135. Lazovich D, Solomon CC, Thomas DB, Moe RE, White E. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer. 1999;86:628-637.
136. Kurtz JM, Jacquemier J, Amalric R, et al. Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer. 1990;65:1867-1878.
137. White JR, Gustafson GS, Wimbish K, et al. Conservative surgery and radiation therapy for infiltrating lobular carcinoma of the breast. The role of preoperative mammograms in guiding treatment. Cancer. 1994;74:640-647.
138. Mansfield CM, Komamicky LT, Schwartz GF, et al. Tenyear results in 1070 patients with stages I and II breast cancer treated by conservative surgery and radiation therapy. Cancer, 1995;75:2328-2336.
139. Dewar JA, Arriagada R, Benhamou S, et al. Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (Institut Gustave Roussy 1970-1982). Cancer. 1995;76:2260-2265.
140. Wazer DE, Morr J, Erban JK, Schmid CH, Ruthazer R, Schmidt-Ullrich RK. The effects of postradiation treatment with tamoxifen on local control and cosmetic outcome in the conservatively treated breast. Cancer. 1997;80:732-740.
141. Kini VR, White JR, Horwitz EM, Dmuchowski CF, Martinez AA, Vicini FA. Long term results with breast-conserving therapy for patients with early stage breast carcinoma in a community hospital setting. Cancer. 1998;82:127-133.
142. Haffty BG, Kornguth P, Fischer D, Beinfield M, McKhann C. Mammographically detected breast Cancer. Results with conservative surgery and radiation therapy. Cancer. 1991;67:2801-2804.
143. Poen JC, Tran L, Juillard G, et al. Conservation therapy for invasive lobular carcinoma of the breast. Cancer. 1992;69:2789-2795.
144. Pierce L, Fowble B, Solin LJ, Schultz DJ, Rosser C, Goodman RL. Conservative surgery and radiation therapy in black women with early stage breast Cancer. Cancer. 1992;69:2831-2841.
145. Levitt SH. Radiation oncology. Cancer. 1990;65:2119-2120.
146. Harris JR, Recht A, Connolly J, et al. Conservative surgery and radiotherapy for early breast Cancer. Cancer. 1990;66:1427-1438.
147. Schnitt SJ, Abner A, Gelman R, et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer. 1994;74:1746-1751.
148. Gage I, Schnitt SJ, Nixon AJ, et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer. 1996;78:1921-1928.
149. Smitt MC, Nowels KW, Zdeblick MJ, et al. The importance of lumpectomy surgical margin status in long term results of breast conservation. Cancer. 1995;76:259-267.
150. Heimann R, Powers C, Halpern HJ, et al. Breast preservation in stage I and II carcinoma of the breast. The University of Chicago experience. Cancer. 1996;78:1722-1730.
151. DiBiase SJ, Komarnicky LT, Schwartz GF, Xie Y, Mansfield CM. The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma. Cancer. 1998;82:2212-2220.
152. Neuschatz AC, DiPetrillo T, Safaii H, Price LL, Schmidt-Ullrich RK, Wazer DE. Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy. Cancer. 2003;97:30-39.
153. Leong C, Boyages J, Jayasinghe UW, et al. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Cancer. 2004;100:1823-1832.
154. Fisher ER, Anderson S, Tan-Chiu E, Fisher B, Eaton L, Wolmark N. Fifteen-year prognostic discriminants for invasive breast carcinoma. National Surgical Adjuvant Breast and Bowel Project Protocol-06. Cancer. 2001;91:1679-1687.
155. Sastre-Garau X, Jouve M, Asselain B, et al. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer. 1996;77:113-120.
156. Nixon AJ, Schnitt SJ, Gelman R, et al. Relationship of tumor grade to other pathologic features and to treatment outcome of patients with early stage breast carcinoma treated with breast-conserving therapy. Cancer. 1996;78:1426-1431.
157. Silverstein MJ, Lewinsky BS, Waisman JR, et al. Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer. 1994;73:1673-1677.
158. Nemoto T, Patel JK, Rosner D, Dao TL, Schuh M, Penetrante R. Factors affecting recurrence in lumpectomy without irradiation for breast Cancer. Cancer. 1991;67:2079-2082.
159. Schnitt SJ, Hayman J, Gelman R, et al. A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast Cancer. Cancer. 1996;77:1094-1100.
160. Solin LJ, Fowble BL, Schultz DJ, Goodman RL. The impact of mammography on the patterns of patients referred for definitive breast irradiation. Cancer. 1990;65:1085-1089.
161. Silverstein MJ, Waisman JR, Gamagami P, et al. Intraductal carcinoma of the breast (208 cases). Clinical factors influencing treatment choice. Cancer. 1990;66:102-108.
162. Bornstein BA, Recht A, Connolly JL, et al. Results of treating ductal carcinoma in situ of the breast with conservative surgery and radiation therapy. Cancer. 1991;67:7-13.
163. Solin LJ, Recht A, Fourquet A, et al. Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast. Cancer. 1991;68:2337-2344.
164. Van Zee KJ, Liberman L, Samli B, et al. Long-term followup of women with ductal carcinoma in situ treated with breast-conserving surgery. The effect of age. Cancer. 1999; 86:1757-1767.
165. Solin LJ, Yeh I, Kurtz J, et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breastconserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment. Cancer. 1993;71:2532-2542.
166. Schwartz GF, Solin LJ, Olivotto IA, Ernster VL, Pressman PI, Committee TCC. Consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999. Cancer. 2000;88:946-954.
167. Schwartz GF, Finkel GC, Garcia JC, Patchefsky AS. Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone. Cancer. 1992;70:2468-2474.
168. Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ. A Metaanalysis. Cancer. 1999;85:616-628.
169. Silverstein MJ, Lagios MD, Craig PH, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer. 1996;77:2267-2274.
170. Fisher ER, Costantino J, Fisher B, Palekar AS, Redmond C, Mamounas E. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Cancer. 1995;75:1310-1319.
171. Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) 8-year update of Protocol B-17. Intraductal carcinoma. Cancer. 1999;86:429-438.
172. Page D, Lagios MD. Pathologic analysis of the National Surgical Adjuvant Breast Project (NSABP) B-17 trial. Unanswered questions remaining unanswered considering current concepts of ductal carcinoma in situ. Cancer. 1995;75:1219-1222.
173. Fisher ER, Costantino J, Fisher B, Palekar AS, Mamounas E. Response - blunting the counterpoint. Cancer. 1995;75:1223-1227.
174. Marcial VA. Primary therapy for limited breast Cancer. Radiation therapy techniques. Cancer. 1990;65:2159-2164.
175. Vicini FA, Beitsch PD, Quiet CA, et al. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity. Results of the American Society of Breast Surgeons MammoSite Brachytherapy Registry Trial. Cancer. 2005;104:1138-1148.
176. Cabioglu N, Hunt KK, Buchholz TA, et al. Improving local control with breast-conserving therapy. A 27-year singleinstitution experience. Cancer. 2005;104:20-29.
177. Pass H, Vicini FA, Kestin LL, et al. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution. Cancer. 2004;101:713-720.
178. Kestin LL, Goldstein NS, Lacerna MD, et al. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy. Cancer. 2000;88:596-607.
179. Vicini FA, Kestin L, Huang R, Martinez A. Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy? Cancer. 2003;97:910-919.
180. Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy. The National Cancer Institute Randomized Trial. Cancer. 2003; 98:697-702.
181. Kroman N, Holtveg H, Wohlfahrt J, et al. Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma. Cancer. 2004; 100:688-693.
182. Zhou P, Recht A. Young age and outcome for women with early-stage invasive breast carcinoma. Cancer. 2004;101:1264-1274.
183. van der Leest M, Evers L, van der Sangen MJC, et al. The safety of breast-conserving therapy in patients with breast cancer aged ≤40 years. Cancer. 2007;109:1957-1964.
184. Robson M, Svahn T, McCormick B, et al. Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2. A clinic-based series. Cancer. 2005;103:44-51.
185. Santiago RJ, Harris EER, Qin L, Hwang W, Solin LJ. Similar long-term results of breast-conservation treatment for stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast. The University of Pennsylvania experience. Cancer. 2005;103:2447-2454.
186. Morrow M, Keeney K, Scholtens D, Wei J, Steel J, Khan SA. Selecting patients for breast-conserving therapy. The importance of lobular histology. Cancer. 2006;106:2563-2568.
187. Sasson AR, Fowble B, Hanlon AL, et al. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast cancer treated with conservative surgery and radiation. Cancer. 2001;91:1862-1869.
188. Abner AL, Connolly JL, Recht A, et al. The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy. Cancer. 2000;88:1072-1077.
189. Ben-David MA, Kleer CG, Paramagul C, Griffith KA, Pierce LJ. Is lobular carcinoma in situ as a component of breast carcinoma a risk factor for local failure after breast-conserving therapy? Results of a matched pair analysis. Cancer. 2006;106:28-34.
190. Weng EY, Juillard GJF, Parker RG, Chang HR, Gornbein JA. Outcomes and
191. Solin LJ, Fourquet A, Vicini FA, et al. Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer. 2005;103:1137-1146.
192. Warren JL, Weaver DL, Bocklage T, et al. The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS. A population-based analysis. Cancer. 2005;104:1840-1848.
193. Chan KC, Knox WF, Sinha G, et al. Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ. Cancer. 2001;91:9-16.
194. MacAusland SG, Hepel JT, Chong FK, et al. An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ. Cancer. 2007; 110:2648-2653.
195. Ceilley E, Jagsi R, Goldberg S, Kachnic L, Powell S, Taghian A. The management of ductal carcinoma in situ in North America and Europe. Results of a survey. Cancer. 2004;101:1958-1967.
196. Benda RK, Yasuda G, Sethi A, Gabram SGA, Hinerman RW, Mendenhall NP. Breast boost: are we missing the target? A dosimetric comparison of 2 boost techniques. Cancer. 2003;97:905-909.
197. Krishnan L, Stanton AL, Collins CA, Liston VE, Jewell WR. Form or function? Pt 2. Objective cosmetic and functional correlates of quality of life in women treated with breast-conserving surgical procedures and radiotherapy. Cancer. 2001;91:2282-2287.
198. Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001;92:1368-1377.
199. Herd-Smith A, Russo A, Muraca MG, Del Turco MR, Cardona G. Prognostic factors for lymphedema after primary treatment of breast carcinoma. Cancer. 2001;92:1783-1787.
200. Yap KPL, McCready DR, Narod S, Manchul LA, Trudeau M, Fyles A. Factors influencing arm and axillary symptoms after treatment for node negative breast carcinoma. Cancer. 2003;97:1369-1375.
201. Jagsi R, Griffith KA, Koelling T, Roberts R, Pierce LJ. Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast Cancer. Cancer. 2007;109:650-657.
202. Huang J, Walker R, Groome PG, Shelley W, Mackillop WJ. Risk of thyroid carcinoma in a female population after radiotherapy for breast carcinoma. Cancer. 2001;92:1411-1418.
203. Zablotska LB, Neugut AI. Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma. Cancer. 2003;97:1404-1411.
204. Deutsch M, Land SR, Begovic M, Wieand HS, Wolmark N, Fisher B. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06. Cancer. 2003;98:1362-1368.
205. Huang J, Mackillop WJ. Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer. 2001;92:172-180.
206. Pawlik TM, Perry A, Strom EA, et al. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma. Cancer. 2004;100:490-498.
207. Shah NM, Tenenholz T, Arthur D, et al. MammoSite and interstitial brachytherapy for accelerated partial breast irradiation. Factors that affect toxicity and cosmesis. Cancer. 2004;101:727-734.
208. Chen PY, Vicini FA, Benitez P, et al. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation. A method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Cancer. 2006;106:991-999.
209. Sauer R, Sautter-Bihl M, Budach W, et al. Accelerated partial breast irradiation. Consensus statement of 3 German oncology societies. Cancer. 2007;110:1187-1194.
210. Schwartz GF, Veronesi U, Clough KB, et al. Proceedings of the Consensus Conference on Breast Conservation, April 28 to May 1, 2005, Milan, Italy. Cancer. 2006;107:242-250.
211. Meric F, Mirza NQ, Vlastos G, et al. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer. 2003;97:926-933.